Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 11, 1999, Pages 2614-2621

  Yamada, Jun ^b   Kurimoto, Iwao ^b   Streilein, J Wayne ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; IMMUNOBIOLOGY; IMMUNOLOGICAL TOLERANCE; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADOPTIVE TRANSFER; ANIMALS; ANTERIOR CHAMBER; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CORNEA; CORNEAL TRANSPLANTATION; GRAFT REJECTION; GRAFT SURVIVAL; HYPERSENSITIVITY, DELAYED; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MINOR HISTOCOMPATIBILITY ANTIGENS; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032879179     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Smith RE, McDonald HR, Nesburn AB, Minckler DS. Penetrating keratoplasty: changing indications, 1947 to 1978. Arch Ophthalmol 1980;98:1226-1229.
2. Sonoda Y, Streilein JW. Orthotopic corneal transplantation in mice-evidence that the immunogenetic rules of rejection do not apply. Transplantation. 1992;54:694-704.
3. Streilein JW, Bradley D, Sano Y, Sonoda Y. Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci. 1996;37:413-424.
4. Niederkorn JY. Immune privilege and immune regulation in the eye. Adv Immunol. 1990;48:191-226.
5. Streilein JW, Wilbanks GA, Cousins SW. Immunoregulatory mechanisms of the eye. J Neuroimmunol. 1992;39:185-200.
6. Yamada J, Streilein JW. Fate of orthotopic corneal allografts in C57BL/6 mice. Transplant Immunol. 1998;6:161-168.
7. Sonoda Y, Sano Y, Ksander B, Streilein JW. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci. 1995;36:427-434.
8. Joo CK, Pepose JS, Stuart PM. T-cell mediated responses in a murine model of orthotopic corneal transplantation. Invest Ophthalmol Vis Sci. 1995;36:1530-1540.
9. Sano Y, Ksander BR, Streilein JW. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction. Invest Ophthalmol Vis Sci. 1995;36:2176-2185.
10. He YG, Ross J, Niederkorn JY. Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest Ophthalmol Vis Sci. 1991;32:2723-2728.
11. Yamada J, Ksander BR, Streilein JW. Cytotoxic T cells play no essential role in rejection of orthotopic corneal allografts in mice [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S9. Abstract nr 38.
12. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 1990;248:1227-1230.
13. Park SH, Roark JH, Bendelac A. Tissue-specific recognition of mouse CD1 molecules. J Immunol. 1998;160:3128-3134.
14. Lee DJ, Abeyratne A, Carson DA, Corr M. Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo. J Exp Med. 1998;187:433-438.
15. Dana MR, Yamada J, Streilein JW. Topical interleukin 1 receptor antagonist promotes corneal transplant survival Transplantation 1997;63:1501-1507.
16. Bacci S, Alard P, Dai R, Nakamura T, Streilein JW. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur J Immunol. 1997;27:442-448.
17. Wilbanks GA, Mammolenti M, Streilein JW. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta. Eur J Immunol. 1992;22:165-173.
18. Sonoda Y, Streilein JW. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J Immunol. 1993;150:1727-1734.
19. Niederkorn JY, Peeler JS, Ross J, Callanan D. The immunogenic privilege of corneal allografts. Reg Immunol. 1989;2:117-124.
20. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation. 1994;57:1295-1302.
21. Sonoda Y, Ksander B, Streilein JW. Evidence that active suppression contributes to the success of H-2-incompatible orthotopic corneal allografts in mice. Transplant Proc. 1993;25:1374-1376.
22. Iwamoto T, Smelser GK. Electron microscope studies on the mast cells and blood and lymphatic capillaries of the human corneal limbus. Invest Ophthalmol. 1965;4:815-834.
23. Streilein JW, Toews GB, Bergstresser PR. Corneal allografts fail to express Ia antigens. Nature. 1979;282:326-327.
24. Gebhardt BM. The role of class II antigen-expressing cells in corneal allograft immunity. Invest Ophthalmol Vis Sci. 1990;31:2254-2260.
25. Yamada J, Dana MR, Zhu SN, Alard P, Streilein JW. Interleukin-1 receptor antagonist suppresses allosensitization in corneal transplantation. Arch Ophthalmol. 1998;116:1351-1357.
26. Peeler JS, Niederkorn JY. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J Immunol. 1986;136:4362-4371.
27. Nicholls SM, Shimeld C, Easty DL, Hill TJ. Recurrent herpes simplex after corneal transplantation in rats. Invest Ophthalmol Vis Sci. 1996;37:425-435.
28. Streilein JW, Streilein JS. Immunologic reactivity to weak transplantation antigens: factors which favor sensitization rather than tolerance. J Natl Cancer Inst. 1973;51:1589-1595.
29. Katz DH, Ellman L, Paul WE, Green I, Benacerraf B. Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells. Cancer Res. 1972;32:133-140.
30. Loveland BE, McKenzie IF. Which T cells cause graft rejection? Transplantation. 1982;33:217-221.
31. Steinmuller D. Which T cells mediate allograft rejection? Transplantation. 1985;40:229-233.
32. Krieger NR, Yin DP, Fathman GC. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med. 1996;184:2013-2018.